Molecular Templates, Inc.
Molecular Templates, Inc. (MTEM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MTEM · as of Jun 9, 2026
Key Statistics
Explore Molecular Templates, Inc. Data
mtem stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 75.0%
Competitors & Peers
mtem competitorsMTEM
ACGJ
ALNAQ
ARTH
BLEVF
EPRSQStock Performance
Full HistoryAbout Molecular Templates, Inc.
Molecular Templates, Inc. (MTEM) is a clinical-stage biopharmaceutical firm dedicated to the identification and progression of biological therapies for oncology and other significant health conditions…
what is molecular templates, inc. · mtem stock overview · molecular templates, inc. company profile · who is molecular templates, inc. ceo · mtem OTC · molecular templates, inc. headquarters · molecular templates, inc. business segments
About Stock Overview & Key Data
Molecular Templates, Inc. (MTEM) is a Healthcare company in the Biotechnology industry, listed on OTC since Feb 4, 2005. As of the latest trading session, MTEM stock price is $0.00, with a market capitalization of $658. The stock has returned -99.89% over the past 12 months and -88.46% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Molecular Templates, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Molecular Templates, Inc. reported revenue of $57.3M and net income of -$8.1M. For detailed data — including Molecular Templates, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Molecular Templates, Inc. (MTEM) stock price is $0.00. The stock is traded on OTC under the ticker symbol MTEM. The 52-week range is $0.00 – $1.59.